Solved

Passage Tumor Hypoxia Is a Marker of Resistance to Chemotherapy and and Radiation

Question 1

Multiple Choice

Passage
Tumor hypoxia is a marker of resistance to chemotherapy and radiation.  The low oxygen saturation in solid tumors activates hypoxia-inducible factors (HIFs) , which stimulate the expression of genes required for angiogenesis, erythropoiesis, and glucose utilization.  Under normal conditions, HIF-DNA binding is interrupted by HIF-prolyl hydroxylases (HIF-PHDs) , enzymes that hydroxylate aliphatic residues such as leucine or proline on HIFs.  These hydroxylated residues serve as markers for the ubiquitin-proteasome system.  Researchers have proposed that changes in oxygen-dependent pathways such as the citric acid cycle can regulate HIF-PHD activity.Experiment 1A kinematic study was conducted to test the effect of citric acid cycle intermediates on HIF-PHDs.  Fumarate and succinate were examined with purified HIF-PHD against increasing concentrations of 2-oxoglutarate (2-OG) , an HIF analog.
Passage Tumor hypoxia is a marker of resistance to chemotherapy and radiation.  The low oxygen saturation in solid tumors activates hypoxia-inducible factors (HIFs) , which stimulate the expression of genes required for angiogenesis, erythropoiesis, and glucose utilization.  Under normal conditions, HIF-DNA binding is interrupted by HIF-prolyl hydroxylases (HIF-PHDs) , enzymes that hydroxylate aliphatic residues such as leucine or proline on HIFs.  These hydroxylated residues serve as markers for the ubiquitin-proteasome system.  Researchers have proposed that changes in oxygen-dependent pathways such as the citric acid cycle can regulate HIF-PHD activity.Experiment 1A kinematic study was conducted to test the effect of citric acid cycle intermediates on HIF-PHDs.  Fumarate and succinate were examined with purified HIF-PHD against increasing concentrations of 2-oxoglutarate (2-OG) , an HIF analog.    <strong>Figure 1</strong>  Activity of HIF-PHD exposed to succinate and fumarate in vitro based on 2-OG catalysisExperiment 2Researchers measured HIF-1a, a HIF subunit, using western blot analysis in wild-type (FH<sup>+</sup>)  and fumarate-deficient (FH<sup>−</sup>)  cells that were treated with fumarate under normoxic and hypoxic conditions (Figure 2) .    <strong>Figure 2</strong>  HIF-1a in FH<sup>+</sup> and FH<sup>−</sup> cells grown in vitro under normoxic (N)  and hypoxic (H)  conditions Adapted from Koivunen P, Hirsilä M, Remes AM, Hassinen IE, Kivirikko KI, Myllyharju J. Inhibition of hypoxia-inducible factor (HIF)  hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. J Biol Chem. 2007;282(7) :4524-32. -How is the enzymatic regulation of HIF-PHDs by fumarate and succinate best described? A) Fumarate and succinate are equally effective noncompetitive inhibitors. B) Fumarate is a competitive inhibitor, and succinate is an uncompetitive inhibitor. C) Succinate and fumarate display varying capacity for mixed inhibition. D) Succinate is a more efficient competitive inhibitor than fumarate. Figure 1  Activity of HIF-PHD exposed to succinate and fumarate in vitro based on 2-OG catalysisExperiment 2Researchers measured HIF-1a, a HIF subunit, using western blot analysis in wild-type (FH+) and fumarate-deficient (FH) cells that were treated with fumarate under normoxic and hypoxic conditions (Figure 2) .
Passage Tumor hypoxia is a marker of resistance to chemotherapy and radiation.  The low oxygen saturation in solid tumors activates hypoxia-inducible factors (HIFs) , which stimulate the expression of genes required for angiogenesis, erythropoiesis, and glucose utilization.  Under normal conditions, HIF-DNA binding is interrupted by HIF-prolyl hydroxylases (HIF-PHDs) , enzymes that hydroxylate aliphatic residues such as leucine or proline on HIFs.  These hydroxylated residues serve as markers for the ubiquitin-proteasome system.  Researchers have proposed that changes in oxygen-dependent pathways such as the citric acid cycle can regulate HIF-PHD activity.Experiment 1A kinematic study was conducted to test the effect of citric acid cycle intermediates on HIF-PHDs.  Fumarate and succinate were examined with purified HIF-PHD against increasing concentrations of 2-oxoglutarate (2-OG) , an HIF analog.    <strong>Figure 1</strong>  Activity of HIF-PHD exposed to succinate and fumarate in vitro based on 2-OG catalysisExperiment 2Researchers measured HIF-1a, a HIF subunit, using western blot analysis in wild-type (FH<sup>+</sup>)  and fumarate-deficient (FH<sup>−</sup>)  cells that were treated with fumarate under normoxic and hypoxic conditions (Figure 2) .    <strong>Figure 2</strong>  HIF-1a in FH<sup>+</sup> and FH<sup>−</sup> cells grown in vitro under normoxic (N)  and hypoxic (H)  conditions Adapted from Koivunen P, Hirsilä M, Remes AM, Hassinen IE, Kivirikko KI, Myllyharju J. Inhibition of hypoxia-inducible factor (HIF)  hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. J Biol Chem. 2007;282(7) :4524-32. -How is the enzymatic regulation of HIF-PHDs by fumarate and succinate best described? A) Fumarate and succinate are equally effective noncompetitive inhibitors. B) Fumarate is a competitive inhibitor, and succinate is an uncompetitive inhibitor. C) Succinate and fumarate display varying capacity for mixed inhibition. D) Succinate is a more efficient competitive inhibitor than fumarate. Figure 2  HIF-1a in FH+ and FH cells grown in vitro under normoxic (N) and hypoxic (H) conditions
Adapted from Koivunen P, Hirsilä M, Remes AM, Hassinen IE, Kivirikko KI, Myllyharju J. Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. J Biol Chem. 2007;282(7) :4524-32.
-How is the enzymatic regulation of HIF-PHDs by fumarate and succinate best described?


A) Fumarate and succinate are equally effective noncompetitive inhibitors.
B) Fumarate is a competitive inhibitor, and succinate is an uncompetitive inhibitor.
C) Succinate and fumarate display varying capacity for mixed inhibition.
D) Succinate is a more efficient competitive inhibitor than fumarate.

Correct Answer:

verifed

Verified

Related Questions

Unlock this Answer For Free Now!

View this answer and more for free by performing one of the following actions

qr-code

Scan the QR code to install the App and get 2 free unlocks

upload documents

Unlock quizzes for free by uploading documents